U.S. Hemoglobin A1c Monitoring Markets
Education Campaigns on Seriousness of Diabetes to
Increase Usage of HbA1c Monitors
“Dissemination of information on the graveness of diabetes is expected to do away
with the popular perception of the disease as an easily controlled, low-risk condition,
and consequently, boost demand for glucose and HbA1c monitoring devices.”
Discovery & Diagnostics Analyst Team
Frost & Sullivan
Industry Trends
• HbA1c testing migrating to point of care, POLS
• HbA1c testing moving into patient homes
• Stringent outcomes management incites testing
• MCOs encourage testing to avoid high future costs
• Immunoassay become standard test methodology
Key Features
Frost & Sullivan provides:
• Detailed insights into recent developments and trends
• Drivers, restraints, challenges, and strategic recommendations
• Analyst insights on ‘hot topics’ and emerging applications
in the Discovery and Diagnostics market
• Market sizing and competitive analysis
• Market forecasts and opportunity analysis
What We Offer
• Coverage: The United States
• Proven methodology encompassing extensive primary and
secondary data and research
• Focused information and strategies that cover business and
technology issues
• Credible data and analysis highlighting industry dynamics
• Winning strategies to help you create precise business plans
Who Will Benefit?
Current Market Participants
• Find out how you compare to the competition
• Assess current and future drivers and restraints
• Determine and exploit new market share opportunities
New Entrants
• Analyze challenges associated with the industry
• Calculate time scales for strategy implementation
• Position yourself to capitalize on the market’s unmet needs
Investment Community
• Analyze long-term strategies of HbA1c monitoring companies
• Determine which participants will outperform the competition
• Assess attractiveness of investing in the HbA1c monitoring market
Key Market Participants
Abbott Diagnostics
Bayer Diagnostics/ Bayer Corp.
Beckman Coulter, Inc.
Bio-Rad Laboratories, Inc.
BioSafe Laboratories, Inc.
ChoicePoint Health Systems, Inc./
ChoicePoint, Inc.
Diabetes Technology, Inc.
Flexsite Diagnostics, Inc.
Metrika, Inc.
Olympus America, Inc.
Primus Corp.
Roche Diagnostics
SpectRx, Inc.
Tosoh Corp.
For More Information
• Call toll free 877 GO FROST
(877.463.7876)
• Fax toll free 888.690.3329
• E-mail myfrost@frost.com
• Visit www.frost.com